Leverage Outsourced Partners for Faster, Smarter Product Development

Orthopedic OEMs are increasingly turning to outsourced partners to accelerate innovation, access specialized expertise, and manage costs more effectively. From early-stage design and prototyping to testing, regulatory support, and manufacturing scale-up, the right partners can extend internal capabilities and reduce time to market. Selecting collaborators with proven technical depth, quality systems, and a track record of successful commercialization is critical to maintaining a competitive edge.

Attendees of this session will hear presentations from three contract manufacturers that offer design and manufacturing expertise.

Accelerate Launches & Minimize Costs: Manufacturer of Record & Kitting
Avalign Technologies, Inc. 

For OEMs who manage multiple projects with limited internal resources, outsourcing can help balance workloads and allow internal teams to focus on strategic priorities. A reliable CDMO partner can function as an extension of your organization, enabling OEMs to commercialize more programs without adding internal resources. 

When serving as the Manufacturer of Record (MoR), Avalign Technologies assumes responsibility for design, development, and regulatory compliance, utilizing customer design inputs. Combined with outsourced kitting, this approach can reduce duplicate inspections, improve working capital efficiency, enable more projects, and relieve constrained engineering and operations resources. 

Attendees will learn practical ROI considerations and lessons from real programs. As a trusted CDMO, Avalign can manufacture, source, kit, and hold complete instrument sets, enabling inventory flexibility and a scalable one-stop supplier model that supports faster, more predictable launches.  

Microbiology as a Competitive Advantage in Accelerating MedTech
EXALTA 

Microbiology sits at the intersection of patient safety, regulatory rigor, and time-to-market. As FDA expectations evolve and EU MDR requirements intensify, the way that microbiology is integrated into product development directly shapes launch timelines, regulatory confidence, and commercialization outcomes. 

This session explores how treating microbiology as an integrated development discipline — embedded alongside product development, regulatory, and manufacturing — can materially accelerate medtech programs without compromising safety or compliance. David Hannah, Group Chief Technology Officer will share how in-house microbiology expertise, supported by ISO 17025-accredited capabilities and real-world MDR manufacturing experience, enables earlier insight, tighter development loops, and stronger regulatory readiness, helping medical device companies bring breakthrough innovations to market on compressed, more predictable timelines. 

Bridging Prototype to Production with Fast, Flexible Manufacturing
Lifestyle Medical – Manufacturing Division 

Medical device teams must move fast without compromising quality. Whether supporting early innovators or established OEMs launching line extensions, the challenge is the same: deliver human-use devices quickly and correctly. 

This presentation outlines a manufacturing model built to bridge the gap between prototyping and high-volume production. Lifestyle Medical Manufacturing delivers two-week lead times, efficient small-batch builds, and early Design for Manufacturability collaboration to maintain momentum through pilot, clinical, and early commercialization phases. By avoiding oversized commitments and long queues, teams can build tens to hundreds of units at full medical quality standards. With dedicated capacity, streamlined workflows, and experienced machinists, speed and quality coexist. The result: fewer surprises, fewer deviations, and devices built right the first time.